Findings support the development of a novel peptide vaccine targeting the immunosuppressive effects of Transforming Growth Beta (TGF-β) in ...

A live webcast of the presentation will be available at Events and Presentations. A replay of the webcast will be archived and available following the event.

Transforming growth factor beta 1 (TGFB1), also known as TGF-β1, CED, DPD1, and TGFB, is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted ...

Tribeca Global Natural Resources Ltd. ( ($AU:TGF) ) just unveiled an announcement. Tribeca Global Natural Resources Limited announced its ...

Members of the media are invited to join Martin Imbleau, President and Chief Executive Officer, Alto on Thursday February 20, ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.

Meet, The Ordinary GF 15% Solution, a secret elixir for your skin that promises to lift, firm and smoothen your skin.

Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the ...

Lawyers at Thornton Grout Finnigan, Fasken, Osler, Stikeman Elliott, Goodmans, and Fogler, Rubinoff are listed as representatives in multiple commercial list matters scheduled before the Ontario ...